It has, however, been noted that HER2-negative breast cancers with low ER expression of 1–10% (Low-ER) show molecular features similar to ER-negative breast cancers and are more likely to be basal-like compared to ER-high (>10%) breast cancers3,4. This evidence concerns the gene ERBB2 and breast cancer.